1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK, NY
Mutual Separation Agreement with Mitchell Arnold - VP of Finance
Board Approves 7 Million Restricted Shares for Executives
RSU Grants Approved for Board Members at Petros Pharmaceuticals
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
News, Letter Re Change in Certifying Accountant
Announces Unaudited Pro Forma Consolidated Balance Sheets
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws
Q1
FY 2025
Notice of Late Filing for Annual Report
Q3
Q2
FY 2024
Prospectus filed pursuant to Rule 424(b)(4)
Amended Registration Statement for Securities
Effectiveness Notice
S-1
Registration Statement for Securities Offered under a Shelf Registration
Definitive Proxy Statement
PRER14A
PRE 14A
Additional Proxy Materials
Initial Statement of Beneficial Ownership
Statement of Changes in Beneficial Ownership
Amended Schedule 13G - Ownership Report
Submission Upload
Correspondence
S-1MEF